Medical Imaging in 2025: A Defining Year for Data, AI and Clinical Transformation
Discover how medical imaging in 2025 has evolved with AI integration and population datasets shaping patient care.
Discover how medical imaging in 2025 has evolved with AI integration and population datasets shaping patient care.
Learn about the significance of UK prostate cancer screening and its role in addressing detection and treatment challenges.
Uncover the benefits of radiopharmacy theranostics, bridging chemistry with targeted therapy for enhanced diagnostics.
Learn about the advances in medical imaging that enhance diagnostics and patient experiences through AI and hybrid systems.
Ultrasound cancer treatment is changing cancer care. Find out how this technology offers a non-invasive alternative to surgery.
Uncover the significance of the Google Willow quantum chip, a leap in processor technology that outperforms classical supercomputers.
Discover Japan’s new domestic quantum computer, a significant achievement in national technological independence and innovation.
Scotland’s first total-body scanner enhances medical imaging capabilities, enabling high-resolution images for better patient care.
Find out how generative AI antibiotics are paving the way for new solutions to modern infections and antimicrobial resistance.
Uncover the facts about MRI safety and metal objects. Find out how these items can become dangerous projectiles in MRI environments.
Learn about the UK Biobank’s pioneering imaging study that has delivered unique insights from 100,000 participant scans.
AI algorithms revolutionise tumour detection in medical imaging, enhancing precision, automating analysis, and supporting personalised cancer treatment through advanced PET/CT integration.
[18F]flurpiridaz PET shows superior sensitivity and lower radiation in detecting coronary artery disease compared to SPECT.
[F-18]NAV-4694 shows promise in Alzheimer’s detection, with a strong safety profile and clear regulatory pathways.
Revolutionary miniaturization, cyclotron on a chip heralds compact, efficient particle acceleration, expanding scientific and medical frontiers.
MRI Agent Pixxoscan (Gadobutrol) is an innovative contrast agent that facilitates the visualisation of abnormal structures or lesions.
Whole-body PET imaging transformed medical research, enabling personalised medicine and impacting diagnostics, therapy, and science.
Prostate cancer’s global impact persists; mCRPC, demanding advanced strategies, finds hope in 177Lu-PSMA targeted radioligand therapy.
Pancreatic cancer demands accurate prognosis, improved treatment strategies, and PET radiomic analysis for optimised post-resection outcomes.
Large vessel vasculitis and polymyalgia rheumatica are both inflammatory rheumatic diseases that can result in serious illness if not diagnosed.
Radiomics offers non-invasive, quantitative image analysis for predicting breast cancer patients’ response to neoadjuvant chemotherapy, enhancing personalised treatment.
Brachial plexus imaging is vital for diagnosing nerve conditions; ultrasound’s potential challenges MRI’s traditional dominance in this area.
Lung cancer’s high mortality demands early detection; advances like low-dose CT and photon-counting CT improve noninvasive, accurate screening outcomes.